TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Imagion Biosystems Ltd. ( (AU:IBX) ) has issued an announcement.
Imagion Biosystems Limited reported a significant financial loss for the half-year ending June 30, 2025, with no revenue from ordinary activities and an 8.8% increase in losses compared to the previous period. The company did not declare any dividends, and its net tangible assets per ordinary security decreased, reflecting ongoing financial challenges.
More about Imagion Biosystems Ltd.
Imagion Biosystems Limited operates in the biotechnology industry, focusing on the development of medical imaging technology. The company is primarily engaged in creating non-radioactive diagnostic imaging solutions aimed at improving the early detection of cancer.
Average Trading Volume: 4,854,766
Technical Sentiment Signal: Sell
Current Market Cap: A$3.94M
Learn more about IBX stock on TipRanks’ Stock Analysis page.